Implications of COVID-19 for patients with pre-existing digestive diseases
Mao, R., Liang, J., Shen, J., Ghosh, S., Zhu, L., Yang, H., . . . Chen, M. (2020). Implications of COVID-19 for patients with pre-existing digestive diseases. The Lancet Gastroenterology & Hepatology, 5(5), 425-427. doi:10.1016/s2468-1253(20)30076-5 https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30076-5/fulltext
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Obesity Could Shift Severe COVID-19 Disease to Younger Ages
Implications of COVID-19 for patients with pre-existing digestive diseases
Comorbidities and multi-organ injuries in the treatment of COVID-19
Liver injury in COVID-19: management and challenges
COVID-19: consider cytokine storm syndromes and immunosuppression
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: A multicentre, retrospective, cohort study
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
COVID-19 in patients with HIV: clinical case series
Maintaining HIV care during the COVID-19 pandemic
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumor subtype and patient demographics: a prospective cohort study
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study